1. Home
  2. RFL vs FLYX Comparison

RFL vs FLYX Comparison

Compare RFL & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • FLYX
  • Stock Information
  • Founded
  • RFL 2017
  • FLYX 2015
  • Country
  • RFL United States
  • FLYX United States
  • Employees
  • RFL N/A
  • FLYX N/A
  • Industry
  • RFL Real Estate
  • FLYX Blank Checks
  • Sector
  • RFL Finance
  • FLYX Finance
  • Exchange
  • RFL Nasdaq
  • FLYX Nasdaq
  • Market Cap
  • RFL 48.4M
  • FLYX 54.1M
  • IPO Year
  • RFL N/A
  • FLYX N/A
  • Fundamental
  • Price
  • RFL $1.66
  • FLYX $2.77
  • Analyst Decision
  • RFL
  • FLYX
  • Analyst Count
  • RFL 0
  • FLYX 0
  • Target Price
  • RFL N/A
  • FLYX N/A
  • AVG Volume (30 Days)
  • RFL 450.8K
  • FLYX 12.5K
  • Earning Date
  • RFL 06-11-2025
  • FLYX 08-13-2025
  • Dividend Yield
  • RFL N/A
  • FLYX N/A
  • EPS Growth
  • RFL N/A
  • FLYX N/A
  • EPS
  • RFL N/A
  • FLYX N/A
  • Revenue
  • RFL $732,000.00
  • FLYX $335,427,000.00
  • Revenue This Year
  • RFL N/A
  • FLYX $28.47
  • Revenue Next Year
  • RFL N/A
  • FLYX $22.44
  • P/E Ratio
  • RFL N/A
  • FLYX N/A
  • Revenue Growth
  • RFL 35.56
  • FLYX 5.38
  • 52 Week Low
  • RFL $1.27
  • FLYX $1.79
  • 52 Week High
  • RFL $3.19
  • FLYX $5.19
  • Technical
  • Relative Strength Index (RSI)
  • RFL 46.95
  • FLYX 49.45
  • Support Level
  • RFL $1.41
  • FLYX $2.77
  • Resistance Level
  • RFL $1.70
  • FLYX $2.89
  • Average True Range (ATR)
  • RFL 0.28
  • FLYX 0.24
  • MACD
  • RFL -0.05
  • FLYX 0.00
  • Stochastic Oscillator
  • RFL 11.63
  • FLYX 60.81

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About FLYX flyExclusive Inc.

flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.

Share on Social Networks: